Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-05-13 Sale | 2021-05-14 8:35 pm | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 100,000 | $25.38 | $2,538,000 | 778,958 (Indirect Direct) | View |
| 2021-04-26 Sale | 2021-04-28 8:10 pm | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 50,000 | $25 | $1,250,000 | 628,362 (Indirect Direct) | View |
| 2021-04-01 Sale | 2021-04-02 7:41 pm | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 50,000 | $23 | $1,150,000 | 678,362 (Indirect Direct) | View |
| 2021-02-17 Sale | 2021-02-19 7:57 pm | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 100,000 | $22.43 | $2,242,500 | 805,477 (Indirect Direct) | View |
| 2020-06-04 Sale | 2020-06-05 8:00 pm | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 100,000 | $22.96 | $2,296,000 | 540,843 (Indirect Direct) | View |
| 2020-04-23 Sale | 2020-04-24 8:25 pm | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 100,000 | $26 | $2,600,000 | 640,002 (Indirect Direct) | View |
| 2020-03-04 Sale | 2020-03-06 8:01 pm | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 100,000 | $19.4 | $1,940,000 | 740,002 (Indirect Direct) | View |
| 2020-02-19 Sale | 2020-02-21 8:00 pm | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 40,000 | $21.5 | $860,000 | 340,002 (Indirect Direct) | View |
| 2020-02-07 Sale | 2020-02-07 8:43 pm | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 50,000 | $18.37 | $918,500 | 380,002 (Indirect Direct) | View |
| 2020-01-07 Sale | 2020-01-09 8:27 pm | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 50,000 | $17.96 | $898,000 | 430,002 (Indirect Direct) | View |
| 2019-12-03 Sale | 2019-12-05 8:11 pm | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 50,000 | $16.22 | $811,000 | 468,437 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-07-26 Exercise | 2021-07-28 8:06 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 40,000 | $4.2 | 703,958 (Direct) | View |
| 2021-07-26 Exercise | 2021-07-28 8:06 pm | 2017-02-11 2023-02-10 | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 40,000 | $0 | 703,958 (Direct) | View |
| 2021-07-21 Exercise | 2021-07-23 7:47 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 35,000 | $4.2 | 703,958 (Direct) | View |
| 2021-07-21 Exercise | 2021-07-23 7:47 pm | 2017-02-11 2023-02-10 | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 35,000 | $0 | 703,958 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 11:59 am | 2022-07-01 2031-07-01 | GENOCEA BIOSCIENCES INC. | GNCA | Schwab Gisela Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-05-13 Exercise | 2021-05-14 8:35 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 100,000 | $1.9 | 778,958 (Direct) | View |
| 2021-05-13 Exercise | 2021-05-14 8:35 pm | 2015-07-20 2022-02-04 | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 100,000 | $0 | 778,958 (Direct) | View |
| 2021-04-26 Exercise | 2021-04-28 8:10 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 50,000 | $1.7 | 628,362 (Direct) | View |
| 2021-04-26 Exercise | 2021-04-28 8:10 pm | 2015-07-20 2021-09-18 | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 50,000 | $0 | 628,362 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-02 7:41 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 50,000 | $1.7 | 678,362 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-02 7:41 pm | 2015-07-20 2021-09-18 | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 50,000 | $0 | 678,362 (Direct) | View |
| 2021-03-04 Option Award | 2021-03-05 8:03 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 72,885 | $0 | 628,362 (Direct) | View |
| 2021-02-17 Exercise | 2021-02-19 7:57 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 100,000 | $1.7 | 805,477 (Direct) | View |
| 2021-02-17 Exercise | 2021-02-19 7:57 pm | 2015-07-20 2021-09-18 | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 100,000 | $0 | 805,477 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-17 8:10 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 2,858 | $21.91 | 555,477 (Direct) | View |
| 2021-02-03 Tax Withholding | 2021-02-05 9:16 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 14,982 | $22.56 | 558,335 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 9:16 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 81,038 | $0 | 558,335 (Direct) | View |
| 2020-11-15 Tax Withholding | 2020-11-17 7:57 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 14,953 | $20.16 | 492,279 (Direct) | View |
| 2020-10-22 Tax Withholding | 2020-10-26 8:11 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 55,235 | $21.79 | 506,715 (Direct) | View |
| 2020-10-22 Option Award | 2020-10-26 8:11 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 213,879 | $0 | 506,715 (Direct) | View |
| 2020-09-02 Tax Withholding | 2020-09-04 6:32 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 2,517 | $21.58 | 348,071 (Direct) | View |
| 2020-09-02 Option Award | 2020-09-04 6:32 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 9,745 | $0 | 348,071 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-05 8:00 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 100,000 | $1.7 | 540,843 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-05 8:00 pm | 2015-07-20 2021-09-18 | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 100,000 | $0 | 540,843 (Direct) | View |
| 2020-04-23 Exercise | 2020-04-24 8:25 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 100,000 | $1.7 | 640,002 (Direct) | View |
| 2020-04-23 Exercise | 2020-04-24 8:25 pm | 2015-07-20 2021-09-18 | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 100,000 | $0 | 640,002 (Direct) | View |
| 2020-03-04 Exercise | 2020-03-06 8:01 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 100,000 | $1.7 | 740,002 (Direct) | View |
| 2020-03-04 Exercise | 2020-03-06 8:01 pm | 2015-07-20 2021-09-18 | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 100,000 | $0 | 740,002 (Direct) | View |
| 2020-02-19 Exercise | 2020-02-21 8:00 pm | 2014-09-18 2020-09-17 | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 40,000 | $0 | 340,002 (Direct) | View |
| 2020-02-19 Exercise | 2020-02-21 8:00 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 40,000 | $5.51 | 340,002 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-18 4:41 pm | N/A 2030-02-14 | GENOCEA BIOSCIENCES INC. | GNCA | Schwab Gisela Director | 9,375 | $0 | 9,375 (Direct) | View |
| 2020-02-07 Exercise | 2020-02-07 8:43 pm | 2014-09-18 2020-09-17 | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 50,000 | $0 | 380,002 (Direct) | View |
| 2020-02-07 Exercise | 2020-02-07 8:43 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 50,000 | $5.51 | 380,002 (Direct) | View |
| 2020-01-07 Exercise | 2020-01-09 8:27 pm | 2014-09-18 2020-09-17 | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 50,000 | $0 | 430,002 (Direct) | View |
| 2020-01-07 Exercise | 2020-01-09 8:27 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 50,000 | $5.51 | 430,002 (Direct) | View |
| 2019-12-04 Tax Withholding | 2019-12-06 7:23 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 4,027 | $17.67 | 340,002 (Direct) | View |
| 2019-12-04 Option Award | 2019-12-06 7:23 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 15,592 | $0 | 340,002 (Direct) | View |
| 2019-12-03 Exercise | 2019-12-05 8:11 pm | 2014-09-18 2020-09-17 | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 50,000 | $0 | 468,437 (Direct) | View |
| 2019-12-03 Exercise | 2019-12-05 8:11 pm | N/A N/A | EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | 50,000 | $5.51 | 468,437 (Direct) | View |